Lotus Monthly sales report for November 2022

Lotus today announced that its consolidated sales for November 2022 was NT$1,071,324 thousand, representing a 29% growth over last month and a 9% increase compared to the same period last year.

The growth this month was mainly driven by the strong performance of Export Business, increasing by over 160% MoM and almost 20% YoY – in addition to some delayed shipments of US Buprenorphine/Naloxone from October, Global oncology portfolio also performed well with shipments to European and Latin American markets, partially offset by a softer Asian Business as a result of a seasonable inventory management for anti-obesity portfolio in Korea during the month.

For further information please visit Lotus website.